Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome
This case series examines treatment with anti–programmed cell death 1 (PD1) immunotherapy for patients with basal cell nevus syndrome.
Authors
- Robin Reschke (ORCID: https://orcid.org/0000-0002-2850-2526)
- Jörg Richter (ORCID: https://orcid.org/0000-0002-5823-9618)
- Jessica Cecile Hassel (ORCID: https://orcid.org/0000-0001-7575-6230)
- Alexander Enk (ORCID: https://orcid.org/0000-0002-7358-185X)
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- National Center for Tumor Diseases (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1001/jamadermatol.2024.4445
- Citations
- 2
- Primary Topic
- Hedgehog Signaling Pathway Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.47